SCHEMBL8836701

SCHEMBL8836701

CSc1ccc(-c2nn3cccnc3c2-c2ccncc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.53
MAPK14 Q16539 12/20 0.45
ADORA2A P29274 2/20 0.45
GSK3B P49841 2/20 0.45
EGFR P00533 1/20 0.45
RAF1 P04049 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
ADORA2B P29275 1/20 0.45
ADORA1 P30542 1/20 0.45
MAPK13 O15264 6/20 0.41
MAPK12 P53778 6/20 0.41
MAPK11 Q15759 6/20 0.41
GCGR P47871 4/20 0.39
CSNK1A1 P48729 2/20 0.38
CSNK1D P48730 2/20 0.38
CSNK1E P49674 1/20 0.38
KCNQ3 O43525 2/20 0.38
KCNQ2 O43526 2/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8836442 0.83 PTGS2 (0.70) PTGS2MAPK14ADORA2AGSK3BEGFR
SCHEMBL8836681 0.83 PTGS2 (0.70) PTGS2MAPK14ADORA2AGSK3BEGFR
SCHEMBL17736144 0.77 PTGS2 (0.58) PTGS2MAPK14ADORA2AGSK3BEGFR
SCHEMBL8836705 0.72 PTGS2 (0.43) PTGS2MAPK14ADORA2AGSK3BEGFR
SCHEMBL17128931 0.72 PTGS2 (0.44) PTGS2MAPK14ADORA2AGSK3BEGFR
SCHEMBL4141324 0.72 AXL (0.41) PTGS2MAPK14ADORA2AGSK3BEGFR
SCHEMBL27207655 0.71 MYC (0.43) PTGS2MAPK14ADORA2AGSK3BEGFR
SCHEMBL20770534 0.71 JAK2 (0.55) PTGS2LCKESR1ESR2MAPT
SCHEMBL13772990 0.71 PTGS2 (0.42) PTGS2MAPK14ADORA2AGSK3BEGFR
SCHEMBL4133354 0.71 CYP1A2 (0.44) PTGS2MAPK14ADORA2AGSK3BEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624931-A Pyrazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-29 US disclosed
US-5478827-A Inhibits Interleukin-1 and tumor necrosis factor production FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-12-26 US disclosed
US-5356897-A Inhibit the production of Interleukin-1 and tumor necrosis factor; administering for treatment of chronic inflammatory diseases, autoimmune diseases and sepsis-induced organ injury FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-10-18 US disclosed
EP-0531901-A2 Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-03-17 EP disclosed